NEW YORK (AP) -- Medical device maker Synergetics USA Inc. said Wednesday the Food and Drug Administration approved its VersaVIT surgical system.
The VersaVIT system is designed to be used in vitrectomies, or surgeries were some or all of the vitreous gel is removed from the middle of the eye. The procedures are done in surgeries that repair detached retinas. In a form filed with the Securities and Exchange Commission in 2011, Synergetics said around 320,000 vitrectomies are performed each year in the U.S.
The O'Fallon, Mo., company said European Union regulators are reviewing the VersaVIT system.
Shares of Synergetics rose 7 cents to $3.87 Wednesday, and jumped 78 cents, or 20.2 percent, to $4.65 in after-hours trading.